Pancreatic cancer surveillance

Pancreatic cancer is one of the most challenging cancers to detect early. Symptoms often don’t appear until the disease has progressed or spread to other organs. For individuals with a higher risk due to family history or genetic factors, early screening can make a critical difference.

A patient in a high-risk pancreatic screening program speaks with his physician.

Who is at risk?

You may be at increased risk for pancreatic cancer if you have:

  • A family history of pancreatic cancer in one or more first-degree relatives (parent, sibling, or child) and one or more second-degree relatives (grandparent, grandchild, aunt, uncle, niece, or nephew) on the same side of the family
  • A known genetic mutation such as BRCA1, BRCA2, ATM, PALB2, TP53, or a gene associated with Lynch Syndrome
  • A mutation in CDK2NA (FAMMM Syndrome), STK11 (Peutz-Jeghers Syndrome), or PRSS1 (Hereditary Pancreatitis)

Screening typically begins at age 50, or 10 years earlier than the age at which a family member was diagnosed.

Need to speak with a cancer specialist?

Our multidisciplinary team is here to guide you through every step of your care—from risk assessment to surveillance and beyond.